Publication: SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
dc.contributor.author | Costela-Ruiz, Víctor J | |
dc.contributor.author | Illescas-Montes, Rebeca | |
dc.contributor.author | Puerta-Puerta, Jose M | |
dc.contributor.author | Ruiz, Concepción | |
dc.contributor.author | Melguizo-Rodríguez, Lucia | |
dc.date.accessioned | 2023-02-09T09:35:29Z | |
dc.date.available | 2023-02-09T09:35:29Z | |
dc.date.issued | 2020-06-02 | |
dc.description.abstract | COVID-19 disease, caused by infection with SARS-CoV-2, is related to a series of physiopathological mechanisms that mobilize a wide variety of biomolecules, mainly immunological in nature. In the most severe cases, the prognosis can be markedly worsened by the hyperproduction of mainly proinflammatory cytokines, such as IL-1, IL-6, IL-12, IFN-γ, and TNF-α, preferentially targeting lung tissue. This study reviews published data on alterations in the expression of different cytokines in patients with COVID-19 who require admission to an intensive care unit. Data on the implication of cytokines in this disease and their effect on outcomes will support the design of more effective approaches to the management of COVID-19. | |
dc.identifier.doi | 10.1016/j.cytogfr.2020.06.001 | |
dc.identifier.essn | 1879-0305 | |
dc.identifier.pmc | PMC7265853 | |
dc.identifier.pmid | 32513566 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265853/pdf | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.cytogfr.2020.06.001 | |
dc.identifier.uri | http://hdl.handle.net/10668/15704 | |
dc.journal.title | Cytokine & growth factor reviews | |
dc.journal.titleabbreviation | Cytokine Growth Factor Rev | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen de las Nieves | |
dc.page.number | 62-75 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Review | |
dc.rights.accessRights | open access | |
dc.subject | COVID-19 | |
dc.subject | Chemokines | |
dc.subject | Cytokine storm | |
dc.subject | Growth factors | |
dc.subject | SARS-CoV-2 | |
dc.subject.mesh | Betacoronavirus | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Coronavirus Infections | |
dc.subject.mesh | Cytokine Release Syndrome | |
dc.subject.mesh | Cytokines | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | Pneumonia, Viral | |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Signal Transduction | |
dc.title | SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 54 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1